JACC Specialty Journals

Latest Episodes:

JCO Pulse - Effects of Sacubitril/Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy - SARAH Trial Nov 26, 2024

Show notes

Bonnie Ky, MD, and Marcely Gimenes Bonatto, MD, discuss the study design, findings, future research questions and the potential clinical impact of the use of sacubitril/valsartan for the prevention of cardiotoxicity in high-risk patients undergoing anthracycline chemotherapy.

JACC: Clinical Electrophysiology - Safety and Feasibility of Pulsed Field Ablation in Patients with Mechanical Prosthetic Valves Nov 22, 2024

Show notes

Emile Daoud, MD, Associate Editor of JACC: Clinical Electrophysiology discusses a recently published original research paper on the Safety and Feasibility of Pulsed Field Ablation in Patients with Mechanical Prosthetic Valves

JACC: Cardiovascular Interventions - Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation: 5-Year Results From the EuroSMR Registry Nov 22, 2024

Show notes

Mirza Umair Khalid, MD, social media editor of JACC: Cardiovascular Interventions, and Thomas J. Stocker, MD, discuss a recently published original research paper reporting the long-term outcomes after mitral transcatheter edge-to-edge repair for secondary mitral regurgitation.

Traditional Chinese Medicine in Cardiovascular Disease: Bridging a Cultural Divide Nov 19, 2024

Show notes

What is the current state of evidence behind the use of traditional Chinese medicine in the treatment of cardiovascular disease? Dr. Iokfai Cheang sheds light on this topic through both a clinical and research lens as we discuss the Luobing theory of traditional Chinese medicine.

Cardiac Rehabilitation Nov 19, 2024

Show notes

Dr. Danyan Xu is a chief physician, professor, and the director of the Cardiac Rehabilitation Unit of the Department of Cardiovascular Medicine of the Second Xiangya Hospital, Central South University. She shares insights into cardiac rehabilitation. Moderated by Dr. Zhangling Chen.

JACC: Heart Failure - Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia: REALIZE-K Design and Baseline Characteristics Nov 18, 2024

Show notes

Novi Yanti Sari, MD, social media editor of JACC: Heart Failure, discusses a recently published original research paper that explored new ways to manage hyperkalemia in patients with HFrEF.

JACC: Heart Failure - Optimizing Triage of Ambulatory Patients With Advanced Heart Failure: 2-Year Outcomes From REVIVAL Nov 18, 2024

Show notes

Nikhil Narang, MD, social media editor of JACC: Heart Failure, discusses a recently published original research paper on the clinical trajectory of patients with advanced ambulatory heart failure in the REVIVAL trial.

JACC: Heart Failure - Randomized Trial of Cholesterol Lowering With Evolocumab for Cardiac Allograft Vasculopathy in Heart Transplant Recipients Nov 18, 2024

Show notes

JACC Heart Failure Associate Editor Sean Pinney, MD, discusses a recently published original research paper that explores the results of a randomized controlled trial to test whether evolocumab reduces the burden of cardiac allograft vasculopathy.

JACC: Asia - November 2024 Issue Brief Summary Nov 05, 2024

Show notes

In this episode of the JACC: Asia podcast, Editor-in-Chief Jian'an Wang provides a concise summary of the November 2024 issue, featuring five impactful studies on cardiovascular and metabolic health in Asian populations. Highlights include research on patient mismatch after aortic valve replacement, outcomes of mitral valve repair, and genetic links between lipid levels and type 2 diabetes risk, underscoring the importance of personalized healthcare approaches for Asian patients.

JACC: Asia - Update on Prosthesis–Patient Mismatch Following Transcatheter Aortic Valve Replacement in Asian Patients Nov 05, 2024

Show notes

In this episode of the JACC: Asia podcast, Cheol Hyun Lee explores the prognostic impact of patient-prosthesis mismatch (PPM) following transcatheter aortic valve replacement (TAVR) in Asian patients, who tend to have smaller annular sizes compared to Western populations. The study highlights that while severe PPM occurs in only 1.3% of patients, it is significantly linked to a higher risk of heart failure hospitalization, underscoring the need for personalized treatment approaches in Asia to reduce the risk of severe PPM.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected